OCULAR MYASTHENIA GRAVIS
Clinical trials for OCULAR MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new OCULAR MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for OCULAR MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race against time: can early drug combo halt crippling muscle disease?
Disease control Recruiting nowThis study tests if starting strong anti-inflammatory drugs (corticosteroids) right after diagnosis, and adding a targeted immune drug (rituximab) if needed, can prevent eye muscle weakness from spreading to other muscles in people with ocular myasthenia gravis. It will compare t…
Matched conditions: OCULAR MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Doctors track best drugs to stop eye disease from spreading
Disease control Recruiting nowThis study observes 200 adults in China with new-onset ocular myasthenia gravis, a condition causing droopy eyelids and double vision. It aims to see which standard immunosuppressant medications work best to control the eye symptoms, prevent the disease from spreading to other mu…
Matched conditions: OCULAR MYASTHENIA GRAVIS
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC